Edman degradation is a chemical method that reads a peptide's amino acid sequence one residue at a time, starting at the N-terminus. Phenyl isothiocyanate attaches to the free amine, acid clips that residue off, and chromatography names it. The shortened chain goes around again. It works for roughly 30 to 50 residues and needs an unblocked N-terminus.
- Edman degradation is a stepwise chemical method that uses phenyl isothiocyanate (C7H5NS, 135.19 g/mol) to remove and identify one N-terminal residue of a peptide per cycle.
- Each Edman cycle releases the N-terminal residue as an anilinothiazolinone, which is converted in aqueous acid to a phenylthiohydantoin (PTH) amino acid and identified by its HPLC elution time.
- Automated Edman sequencers can run as many as 50 cycles before by-products accumulate, and practical runs are usually kept under 30 residues.
- Edman degradation needs a free N-terminal amine, so N-terminal acetylation, found on 84 percent of human proteins in a 2009 proteomics study, blocks it.
- Pehr Edman published the method in 1949, and Edman and Begg described the first automated protein sequenator in 1967.
- LabFirst Peptides certificates report identity by LC-MS and purity by RP-HPLC on a C18 column, most read at 214 nm, with net content as a separate line, each by lot number and with a link to the issuing laboratory's site.
What is Edman degradation?
Edman degradation, also called Edman sequencing or N-terminal sequencing, is a stepwise chemical method for determining the amino acid sequence of a peptide. Each cycle removes the amino acid at the N-terminus, identifies it, and hands the rest of the chain back for the next round.
Hand someone a string of beads and ask for the colors in order. The slow but certain way is to slip off the first bead, name it, slip off the next, name it, and keep going until the string runs out. Edman degradation does exactly that with a peptide.
Pehr Edman published the method in 1949 under the plain title "A method for the determination of amino acid sequence in peptides." The reagent at its center is phenyl isothiocyanate, PITC, with the formula C7H5NS and a molecular weight of 135.19 g/mol.
In plain terms, it reads a chain from one end, one link at a time. The method reads in one direction only. A peptide sequence is written from the N-terminus, the end with the free amine, to the C-terminus, the end with the free carboxyl, and Edman chemistry starts at the amine end and works inward. Each cycle removes exactly one residue and leaves every other peptide bond untouched. That is the feature that makes the method work: the chain survives to be read again.
- Coupling: phenyl isothiocyanate binds the free N-terminal amine
- Cleavage: acid clips the first residue off as an ATZ derivative
- Conversion: aqueous acid turns the ATZ into a PTH-amino acid
- Identification: HPLC elution time names the residue
- Repeat: the shortened chain goes back to coupling
How does Edman degradation work? One cycle in four steps
A cycle has four parts, and the same four repeat for every residue.
- Coupling. Phenyl isothiocyanate reacts with the uncharged N-terminal amino group under mildly alkaline conditions, attaching to the first residue. Only a free amine takes part in this step, which is why a capped N-terminus stops everything before it begins.
- Cleavage. Acid, trifluoroacetic acid in the usual protocol, splits the derivatized residue off the chain as an anilinothiazolinone, often written ATZ. The rest of the peptide, now one residue shorter, is left with a fresh N-terminus.
- Conversion. The ATZ derivative is unstable, so it is extracted and treated with aqueous acid, which rearranges it into the more stable phenylthiohydantoin, the PTH-amino acid.
- Identification. The PTH-amino acid is run on HPLC and its elution time is compared with the PTH derivatives of the twenty common amino acids. A match names the residue.
Then the shortened peptide goes back to step one. Edman and Begg built the first automated instrument for this, the protein sequenator, and described it in 1967. Modern sequencers run the cycles unattended and resubmit the chain on their own, and they work with as little as a few picomoles of sample.
What is a PTH-amino acid?
A PTH-amino acid is the phenylthiohydantoin derivative of an amino acid, the stable form each residue takes at the end of an Edman cycle. The residue first leaves the chain as an unstable anilinothiazolinone, and aqueous acid rearranges that into the PTH form.
The PTH form is what the instrument reads. Each of the twenty common amino acids gives a PTH derivative with its own HPLC elution time, so the unknown from each cycle is matched against a set of standards. A clean sample gives one PTH signal per cycle, and the order of those signals across the cycles is the sequence.
How many residues can Edman sequencing read?
Fewer than you might hope. Automated instruments can manage as many as 50 cycles before by-products accumulate and the signal becomes unreadable, and in practice runs are usually kept under 30 residues.
The limit comes from arithmetic. Each cycle converts most of the chain and leaves a little behind, and the leftover fraction starts one residue out of step with the rest. Modern instruments reach over 99 percent efficiency per cycle. At 99 percent, the signal still in step after 30 cycles is 0.99 to the 30th power, about 74 percent (our arithmetic); at 95 percent it is about 21 percent, buried under the out-of-step background. So a long protein is never read in one pass. It is cut into fragments, each fragment is sequenced, and the overlapping ends are matched up. Chains of more than 400 amino acids have been sequenced that way.
What blocks Edman degradation?
The first step needs a free amine at the N-terminus, so anything that caps that amine stops the run at cycle one.
Acetylation. An acetyl group on the N-terminal amine is the most common cap in nature. A 2009 proteomics study found N-terminal acetylation on 84 percent of the human proteins it examined and 57 percent of the yeast proteins, and a 2018 review describes the modification as widespread across eukaryotes and prokaryotes alike. A synthetic peptide made with an acetylated N-terminus is blocked the same way, by design rather than by biology.
Pyroglutamate. An exposed N-terminal glutamine can cyclize on itself into pyroglutamate, which has no free amine. A 2026 crystal structure of a xylanase reported exactly that: spontaneous cyclization once the terminal glutamine was uncovered. An enzyme, pyroglutamate aminopeptidase, can remove the cap before sequencing; the technique was described in 1978.
Other stops. A residue that is not a normal alpha-amino acid, such as isoaspartate, halts the cycle. Disulfide positions are generally not determinable by Edman chemistry, so a cross-linked peptide gives a sequence without its bridges. And a sample carrying more than one N-terminus, from a mixture or a nicked chain, gives more than one PTH signal per cycle.
Why does mass spectrometry do most identity work now?
Much peptide sequencing is now done by mass spectrometry, and for the question a research certificate asks, whether this is the labeled molecule, mass is the better tool. An LC-MS run measures the intact mass of the peptide and compares it with the mass the sequence predicts. A match within the instrument's accuracy is strong evidence of composition, and a mismatch is decisive. The measurement needs no free N-terminus and sees the whole molecule at once, modifications included. Our LC-MS identity testing guide walks through how that comparison is made and what a report has to show.
When the order of residues has to be proved, tandem mass spectrometry fragments the peptide and reads the sequence from the mass differences between fragment ions. Bottom-up proteomics, where a protein is cut into tryptic peptides and each one is identified from its fragments, is the preferred method in proteomic studies. The MALDI-TOF versus ESI guide covers the two ways of getting a peptide into the gas phase.
Edman degradation vs mass spectrometry
Edman chemistry reads the order of residues directly, from one end. Mass spectrometry weighs the molecule and works the order out from its fragments.
| Question | Edman degradation | Mass spectrometry |
|---|---|---|
| What it reads | One residue per cycle, from the N-terminus | The mass of the whole molecule, or of its fragments |
| Direction | N-terminus inward only | No direction; sequence comes from fragment mass differences |
| Practical read length | Usually under 30 residues, up to about 50 | Whole peptide at once; proteins by fragments |
| Blocked N-terminus | Stops the run | Shows up as a mass shift |
| Modifications | Can stop the cycle | Measured as part of the mass |
| Instrument | Protein sequenator with HPLC for PTH residues | LC-MS, MALDI-TOF or ESI with tandem MS |
| Role today | Confirming one end of a chain | Routine identity and sequence work |
Is Edman degradation still used?
Yes, for a narrower job than it once had. What Edman still does well is answer one question with no database and no fragmentation: which residue sits at the N-terminus, and which comes next. Confirming one end of a chain is its role today, while routine identity and sequence work has moved to LC-MS, MALDI-TOF or ESI instruments with tandem MS.
The requirements are strict. The sample needs a free amine at the N-terminus, and it needs a single N-terminus, since a mixture or a nicked chain gives more than one PTH signal per cycle. Inside those limits a modern sequencer runs unattended on as little as a few picomoles of sample.
What does this mean for a peptide certificate?
On a research peptide certificate, identity is normally a mass result. Every certificate LabFirst Peptides publishes reports identity by LC-MS, purity by RP-HPLC on a C18 column, and net content as its own line, each by lot number, and the certificate index holds the record for each lot. The identity line is a comparison of measured mass against the mass the sequence predicts, which is the Edman question answered from the other direction. The chain was built to a sequence, and the mass says whether the finished molecule matches it.
Reading one, look for the sequence the comparison was made against, the measured and theoretical masses, and the difference between them. The purity versus identity guide explains why that mass line and the purity line answer different questions and have to be read together.
FOR LABORATORY AND IN-VITRO RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Common questions
What is Edman degradation used for?
What reagent is used in Edman degradation?
What is a PTH-amino acid?
Why is Edman sequencing limited to about 30 to 50 residues?
Can Edman degradation sequence a peptide with an acetylated N-terminus?
What is the difference between Edman degradation and mass spectrometry for sequencing?
Who invented Edman degradation?
More science guides
Sources
- OpenStax Organic Chemistry, 26.6 Peptide Sequencing: The Edman Degradation (Chemistry LibreTexts). The reagent, TFA cleavage to the ATZ derivative, conversion to the PTH-amino acid, identification by elution time, up to 50 cycles per run, picomole sample amounts, overlap sequencing of chains over 400 residues, and the role of mass spectrometry.
- Jakubowski and Flatt, Fundamentals of Biochemistry, 3.4 Analyses of Protein Structure (Biology LibreTexts). Coupling under mildly alkaline conditions, the thiazolinone intermediate, practical read length under 30 residues, over 99 percent efficiency per cycle, blocked N-termini (acetylation, pyroglutamate), isoaspartate, disulfide positions, and bottom-up mass spectrometry.
- Edman, A method for the determination of amino acid sequence in peptides, Archives of Biochemistry 22:475 (1949) . The original description of the method; record opened through PubMed (PMID 18134557).
- Edman and Begg, A protein sequenator, European Journal of Biochemistry 1:80 (1967) doi:10.1111/j.1432-1033.1967.tb00047.x. The first automated Edman instrument; record opened through Europe PMC and PubMed.
- Arnesen et al., Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans, PNAS 106:8157 (2009) doi:10.1073/pnas.0901931106. N-terminal acetylation found on 84 percent of human and 57 percent of yeast proteins examined.
- Ree, Varland and Arnesen, Spotlight on protein N-terminal acetylation, Experimental and Molecular Medicine 50:1 (2018) doi:10.1038/s12276-018-0116-z. Review describing N-terminal acetylation as widespread among eukaryotes and prokaryotes.
- Podell and Abraham, A technique for the removal of pyroglutamic acid from the amino terminus of proteins using calf liver pyroglutamate amino peptidase, Biochem Biophys Res Commun 81:176 (1978) doi:10.1016/0006-291x(78)91646-7. Enzymatic removal of an N-terminal pyroglutamate cap before sequencing.
- Mijatovic, Mueller, Weiss and Lennartz, Structure of recombinant Thermoascus aurantiacus xylanase TaXyn10 with an authentic N-terminal pyroglutamate, Acta Crystallographica Section F (2026) doi:10.1107/s2053230x26009155. Spontaneous cyclization of an exposed N-terminal glutamine to pyroglutamate.
- PubChem PUG REST: formula and molecular weight for phenyl isothiocyanate (CID 7673). C7H5NS, 135.19 g/mol.
